[go: up one dir, main page]

CN116725003B - Stem cell cryopreservation solution and stem cell cryopreservation method - Google Patents

Stem cell cryopreservation solution and stem cell cryopreservation method Download PDF

Info

Publication number
CN116725003B
CN116725003B CN202311007396.8A CN202311007396A CN116725003B CN 116725003 B CN116725003 B CN 116725003B CN 202311007396 A CN202311007396 A CN 202311007396A CN 116725003 B CN116725003 B CN 116725003B
Authority
CN
China
Prior art keywords
stem cell
cell cryopreservation
antifreeze
weight
cryopreservation solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202311007396.8A
Other languages
Chinese (zh)
Other versions
CN116725003A (en
Inventor
王泰华
王兴昕
姜晓霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saier Medical Technology Shandong Co ltd
Original Assignee
Saier Medical Technology Shandong Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saier Medical Technology Shandong Co ltd filed Critical Saier Medical Technology Shandong Co ltd
Priority to CN202311007396.8A priority Critical patent/CN116725003B/en
Publication of CN116725003A publication Critical patent/CN116725003A/en
Application granted granted Critical
Publication of CN116725003B publication Critical patent/CN116725003B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/125Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/16Physical preservation processes
    • A01N1/162Temperature processes, e.g. following predefined temperature changes over time

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明涉及干细胞冻存技术领域,具体提供了一种干细胞冻存液及干细胞冻存方法;干细胞冻存液使用重量份数为43~58%的抗冻组合物和补足余量的干细胞培养基;所述抗冻组合物为重量份数为30~35%的抗冻提取物、重量份数为3%的原儿茶酸、重量份数为2%的香豆素、重量份数为6%的槲皮素和补足余量的甘油。本发明在冻存液中使用了本发明独特比例的抗冻组合物,配合本发明独特的干细胞冻存方法,通过改善子宫内膜干细胞内外晶核结冰的速率和冰晶的形态、保护包括酶活在内的胞内环境,使复苏后甚至反复冻融后子宫内膜干细胞有较高的存活率和增殖能力。The invention relates to the technical field of stem cell cryopreservation, and specifically provides a stem cell cryopreservation solution and a stem cell cryopreservation method; the stem cell cryopreservation solution uses an antifreeze composition of 43 to 58% by weight and a stem cell culture medium to make up the balance. ; The antifreeze composition is 30 to 35% by weight of antifreeze extract, 3% by weight of protocatechuic acid, 2% by weight of coumarin, and 6% by weight. % of quercetin and make up the balance of glycerin. The present invention uses the unique proportion of the antifreeze composition of the present invention in the cryopreservation solution, and cooperates with the unique stem cell cryopreservation method of the present invention, by improving the freezing rate of the inner and outer crystal nuclei of endometrial stem cells and the morphology of ice crystals, protecting enzymes including The living intracellular environment allows endometrial stem cells to have a higher survival rate and proliferation ability after recovery and even after repeated freezing and thawing.

Description

一种干细胞冻存液及干细胞冻存方法Stem cell cryopreservation solution and stem cell cryopreservation method

技术领域Technical field

本发明涉及干细胞冻存技术领域,尤其涉及一种干细胞冻存液及干细胞冻存方法。The present invention relates to the technical field of stem cell cryopreservation, and in particular to a stem cell cryopreservation solution and a stem cell cryopreservation method.

背景技术Background technique

干细胞是一类具有自我复制能力的多潜能细胞。在一定条件下,它可以分化成多种功能细胞。根据干细胞所处的发育阶段分为胚胎干细胞和成体干细胞。根据干细胞的发育潜能分为三类:全能干细胞、多能干细胞和单能干细胞。干细胞是一种未充分分化,尚不成熟的细胞,具有再生各种组织器官和人体的潜在功能。Stem cells are a type of pluripotent cells with the ability to replicate themselves. Under certain conditions, it can differentiate into a variety of functional cells. According to the developmental stage of stem cells, they are divided into embryonic stem cells and adult stem cells. Stem cells are divided into three categories according to their developmental potential: totipotent stem cells, pluripotent stem cells and unipotent stem cells. Stem cells are cells that are not yet fully differentiated and immature and have the potential to regenerate various tissues, organs and the human body.

子宫内膜干细胞是一种成体干细胞,具有自我更新、多向分化和高度增殖的潜能。目前大量研究已证实子宫内膜中存在干细胞样细胞从而使子宫内膜具有很强的再生能力;早在1978年就有研究提出子宫内膜功能层增生修复可能是由于子宫内膜干细胞的作用,随后进行的一系列临床和基础研究均证实了这一假说。子宫内膜再生和分化为其他组织的潜能已得到越来越多的关注并可能成为子宫内膜过薄和内膜病变患者进行内膜修复替代治疗的手段。Endometrial stem cells are a type of adult stem cells with the potential of self-renewal, multi-directional differentiation and high proliferation. At present, a large number of studies have confirmed that the existence of stem cell-like cells in the endometrium gives the endometrium a strong regenerative ability; as early as 1978, studies suggested that the proliferation and repair of the functional layer of the endometrium may be due to the effect of endometrial stem cells. A series of subsequent clinical and basic studies confirmed this hypothesis. The potential of the endometrium to regenerate and differentiate into other tissues has received increasing attention and may become an alternative treatment for endometrial repair in patients with thin endometrium and endometrial lesions.

为了使子宫内膜干细胞暂时脱离生长状态,保存其细胞特性并在需要的时候再复苏细胞,常常利用冻存技术将细胞置于-196℃液氮中低温保存,这样可以防止因正在培养的细胞被污染或其他意外事件而使细胞丢种。然而,在冻结时,细胞内水分透出,冰晶形成造成细胞损伤,在复苏细胞时,水分渗入细胞内形成胞内再结晶也造成细胞损伤。现有的技术多是使用DMSO或者甘油等作为冻存的保护剂,但是复苏后细胞的存活率较低,即便存活其增殖能力往往不高;此外现有冻存液不支持反复冻融,对储运和分批次使用干细胞带来了不便。因此,提供一种复苏后甚至反复冻融后子宫内膜干细胞的存活率和增殖能力较高的细胞冻存液具有重要的现实意义。In order to temporarily remove the endometrial stem cells from the growth state, preserve their cell characteristics and resuscitate the cells when needed, cryopreservation technology is often used to store the cells in -196°C liquid nitrogen, which can prevent the cells from being cultured. Cells are lost due to contamination or other accidents. However, when freezing, water leaks out of the cells and ice crystals form, causing cell damage. When cells are revived, water seeps into the cells to form intracellular recrystallization, which also causes cell damage. Existing technologies mostly use DMSO or glycerol as protective agents for cryopreservation, but the survival rate of cells after recovery is low, and even if they survive, their proliferation ability is often not high; in addition, the existing cryopreservation solutions do not support repeated freezing and thawing, which is harmful to Storing, transporting and using stem cells in batches brings inconvenience. Therefore, it is of great practical significance to provide a cell cryopreservation solution that has a higher survival rate and proliferation ability of endometrial stem cells after recovery or even repeated freezing and thawing.

发明内容Contents of the invention

为了解决上述问题,本发明目的是提供一种干细胞冻存液及干细胞冻存方法。In order to solve the above problems, the purpose of the present invention is to provide a stem cell cryopreservation solution and a stem cell cryopreservation method.

一方面,本发明提供了一种干细胞冻存液,所述干细胞冻存液由以下组分组成:On the one hand, the present invention provides a stem cell cryopreservation solution, which is composed of the following components:

重量份数为43~58%的抗冻组合物和补足余量的干细胞培养基;The antifreeze composition is 43~58% by weight and the stem cell culture medium makes up the balance;

所述抗冻组合物为重量份数为30~35%的抗冻提取物、重量份数为3%的原儿茶酸、重量份数为2%的香豆素、重量份数为6%的槲皮素和补足余量的甘油;The antifreeze composition is 30 to 35% by weight of antifreeze extract, 3% by weight of protocatechuic acid, 2% by weight of coumarin, and 6% by weight. of quercetin and glycerin to make up the balance;

所述抗冻提取物的提取方法包括:The extraction method of the antifreeze extract includes:

步骤一:将成年虹鳟于2℃下饲养2周,收集400ml鱼血和300g鱼肉;Step 1: Raise adult rainbow trout at 2°C for 2 weeks, collect 400ml of fish blood and 300g of fish meat;

步骤二:在2℃下,将鱼血和鱼肉放入闪式提取器,转速3600~4700r/min,提取17~28s后50目滤网过滤,得粗滤提取液;Step 2: Put the fish blood and fish meat into the flash extractor at 2°C, rotate at 3600~4700r/min, extract for 17~28s and then filter through a 50-mesh filter to obtain a coarse-filtered extract;

步骤三:在4℃下,向粗滤混合液中加入等体积的甘油,通过SV型静态混合器循环混合60~70s,150目过滤得精滤提取液,混合器空隙率为0.909%;Step 3: At 4°C, add an equal volume of glycerin to the coarse filter mixture, mix it in a SV-type static mixer for 60 to 70 seconds, and filter it with 150 mesh to obtain a fine filter extract. The void ratio of the mixer is 0.909%;

步骤四:将混合液放入离心机,每5ml离心3min,转速6200~6900r/min,取上清液;Step 4: Put the mixed solution into a centrifuge, centrifuge for 3 minutes per 5ml at a speed of 6200~6900r/min, and take the supernatant;

步骤五:将上清液于40℃下,真空度600~800mbar减压蒸馏至无液体继续流出,收集馏出液得抗冻提取物。Step 5: Distill the supernatant under reduced pressure at 40°C with a vacuum of 600~800mbar until no liquid continues to flow out, and collect the distillate to obtain the antifreeze extract.

进一步地,所述抗冻组合物的重量份数为54%。Further, the weight portion of the antifreeze composition is 54%.

进一步地,所述抗冻提取物的重量份数为33%。Further, the weight portion of the antifreeze extract is 33%.

进一步地,所述步骤二中闪式提取过程为4400r/min,提取23s。Further, the flash extraction process in step two is 4400r/min, and the extraction takes 23 seconds.

进一步地,所述步骤三中混合时间为66s。Further, the mixing time in step three is 66 seconds.

进一步地,所述步骤四中离心转速为6700r/min。Further, the centrifugal speed in step 4 is 6700 r/min.

进一步地,所述步骤五中真空度为700mbar。Further, the vacuum degree in step five is 700mbar.

另一方面,本发明提供了一种干细胞冻存方法,所述方法包括:On the other hand, the present invention provides a stem cell cryopreservation method, which method includes:

步骤一:25℃下将子宫内膜干细胞与所述干细胞冻存液混合,得降温体系,所述子宫内膜干细胞在所述降温体系中的最终数量密度为7×105/mL;Step 1: Mix endometrial stem cells and the stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of the endometrial stem cells in the cooling system is 7×105/mL;

步骤二:使用程序降温仪,以-2℃/ min的降温速率将温度降至-25~-30℃,以-4~-6℃/ min的降温速率将温度降至-75~-80℃,以-10~-12℃/ min的降温速率将温度降至-110~-115℃;Step 2: Use the programmed cooling device to lower the temperature to -25~-30°C at a cooling rate of -2°C/min, and to -75~-80°C at a cooling rate of -4~-6°C/min. , reduce the temperature to -110~-115°C at a cooling rate of -10~-12°C/min;

步骤三:移入-196℃液氮,完成冻存。Step 3: Move into -196°C liquid nitrogen to complete freezing.

进一步地,所述干细胞冻存方法包括:Further, the stem cell cryopreservation method includes:

步骤一:25℃下将子宫内膜干细胞与所述干细胞冻存液混合,得降温体系,所述子宫内膜干细胞在所述降温体系中的最终数量密度为7×105/mL;Step 1: Mix endometrial stem cells and the stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of the endometrial stem cells in the cooling system is 7×105/mL;

步骤二:使用程序降温仪,以-2℃/ min的降温速率将温度降至-27℃,以-5℃/min的降温速率将温度降至-78℃,以-11℃/ min的降温速率将温度降至-114℃;Step 2: Use the programmed cooling device to lower the temperature to -27°C at a cooling rate of -2°C/min, to -78°C at a cooling rate of -5°C/min, and to -11°C/min. rate reduces the temperature to -114°C;

步骤三:移入-196℃液氮,完成冻存。Step 3: Move into -196°C liquid nitrogen to complete freezing.

通过本发明能够带来如下有益效果:The present invention can bring the following beneficial effects:

生活在低温环境中的虹鳟等生物要避免体液结冰,长期的进化过程使其体内出现了广泛且多样化的抗冻物质。本发明的闪式提取方法,在充分破碎鱼组织的同时,减少对其抗冻物质的破坏,尤其是长时间高温破坏,使抗冻物质有足够的活性通过后续处理;本发明用静态混合器混合的方法,利用湍流和层流的不同区域比例,充分混合粗滤混合液和甘油,避免了抗冻物质的凝集,减少了后续过滤的抗冻物质损失;本发明的离心转速在保留合适抗冻物质的同时,去除了较大杂质,提高了后续蒸馏抗冻物质的纯度,也减少了接触干细胞后的排异反应和环境成分复杂引起的微生物污染;本发明的减压蒸馏方法,减少了高温破坏抗冻物质,并蒸馏出适合的抗冻提取物。Organisms such as rainbow trout living in low-temperature environments need to prevent their body fluids from freezing. The long-term evolutionary process has resulted in the emergence of a wide range and diverse antifreeze substances in their bodies. The flash extraction method of the present invention fully crushes fish tissue while reducing damage to its antifreeze substances, especially long-term high-temperature damage, so that the antifreeze substances have sufficient activity to pass subsequent processing; the present invention uses a static mixer The mixing method utilizes the different regional ratios of turbulent flow and laminar flow to fully mix the coarse filtration mixture and glycerin, thereby avoiding the agglomeration of antifreeze substances and reducing the loss of antifreeze substances in subsequent filtration; the centrifugal speed of the present invention retains appropriate antifreeze. While freezing substances, larger impurities are removed, improving the purity of subsequent distillation of antifreeze substances, and also reducing rejection reactions after contact with stem cells and microbial contamination caused by complex environmental components; the vacuum distillation method of the present invention reduces High temperatures destroy antifreeze substances and distill a suitable antifreeze extract.

本发明采用独特降温速率和温度的三段式降温方法,配合本发明冻存液,既使冻存液充分融入细胞内外环境保护细胞,又避免了长时间较低温状态对细胞的过度破坏,减少了低温及低温形成的冰晶对干细胞内外环境的破坏,配合原儿茶酸的抗菌作用、香豆素的抗凝作用、槲皮素的抗氧化作用,为反复冻融使用干细胞创造了条件。The present invention adopts a three-stage cooling method with a unique cooling rate and temperature, and cooperates with the cryopreservation solution of the present invention, so that the cryopreservation solution can fully integrate into the internal and external environment of the cells to protect the cells, and avoid excessive damage to the cells in a low temperature state for a long time, reducing the It eliminates the damage caused by low temperature and ice crystals formed at low temperatures to the internal and external environment of stem cells, and combined with the antibacterial effect of protocatechuic acid, the anticoagulant effect of coumarin, and the antioxidant effect of quercetin, it creates conditions for repeated freezing and thawing of stem cells.

因此,本发明在冻存液中使用了本发明独特比例的抗冻组合物,配合本发明独特的干细胞冻存方法,通过改善子宫内膜干细胞内外晶核结冰的速率和冰晶的形态、保护包括酶活在内的胞内环境,使复苏后甚至反复冻融后子宫内膜干细胞有较高的存活率和增殖能力。Therefore, the present invention uses the unique proportion of the antifreeze composition of the present invention in the cryopreservation solution, and cooperates with the unique stem cell cryopreservation method of the present invention to improve the freezing rate of the inner and outer crystal nuclei of endometrial stem cells and the morphology and protection of ice crystals. The intracellular environment, including enzyme activity, allows endometrial stem cells to have a higher survival rate and proliferation ability after recovery and even after repeated freezing and thawing.

具体实施方式Detailed ways

此处为了更清楚的阐释本发明的整体构思,下面以实施例的方式对本发明的整体方案进行详细说明;在下文的描述中,给出了大量具体的细节以便提供对本发明更为彻底的理解;然而,对于本领域技术人员来说显而易见的是,本发明可以无需一个或多个这些细节而得以实施;在其他的例子中,为了避免与本发明发生混淆,对于本领域公知的一些技术特征未进行描述。In order to explain the overall concept of the present invention more clearly, the overall solution of the present invention is described in detail below in the form of examples; in the following description, a large number of specific details are given to provide a more thorough understanding of the present invention. ; However, it will be obvious to those skilled in the art that the present invention may be practiced without one or more of these details; in other instances, in order to avoid confusion with the present invention, some technical features that are well known in the art are Not described.

本发明中:甘油、原儿茶酸、香豆素和槲皮素均购自默克化工技术(上海)有限公司,货号分别为G5516、PHL89766、Y0000438和PHR1488;干细胞培养基和子宫内膜干细胞均购自武汉普诺赛生命科技有限公司,货号分别为CM-H230和CP-H230;III型HPLC-12抗冻蛋白购自艾柏森生物科技有限公司,由其菌株Arctic表达,符合蛋白数据库UniProt的登记号P19614的标准;程序降温仪购自江苏爱思科冷冻科技有限公司,型号Cryobox-17s;闪式提取器购自北京金洋万达科技有限公司,型号JHBE-50T;SV型静态混合器购自上海重野实业有限公司,型号SV-3.5/65;离心机购自常州金坛三和仪器有限公司,功率600W;减压蒸馏器购自郑州市亚荣仪器有限公司,型号RE-2000E。In the present invention: glycerin, protocatechuic acid, coumarin and quercetin are all purchased from Merck Chemical Technology (Shanghai) Co., Ltd., and the product numbers are G5516, PHL89766, Y0000438 and PHR1488 respectively; stem cell culture medium and endometrial stem cells Both were purchased from Wuhan Pronosai Life Technology Co., Ltd., with the product numbers of CM-H230 and CP-H230 respectively; Type III HPLC-12 antifreeze protein was purchased from Albertson Biotechnology Co., Ltd., expressed by its strain Arctic, and conforms to the protein database UniProt The standard of registration number P19614; the programmable cooling device was purchased from Jiangsu Aisike Refrigeration Technology Co., Ltd., model Cryobox-17s; the flash extractor was purchased from Beijing Jinyang Wanda Technology Co., Ltd., model JHBE-50T; the SV-type static mixer was purchased from Shanghai Chongye Industrial Co., Ltd., model SV-3.5/65; the centrifuge was purchased from Changzhou Jintan Sanhe Instrument Co., Ltd., with a power of 600W; the vacuum distiller was purchased from Zhengzhou Yarong Instrument Co., Ltd., model RE-2000E.

如未特殊说明,下述实施例中各原料组分均可通过商业途径购得,所使用的实验仪器均为实验室常规实验仪器,性能测试方法为本领域已知测试方法。Unless otherwise specified, each raw material component in the following examples can be purchased through commercial channels, the experimental instruments used are all conventional laboratory experimental instruments, and the performance test methods are test methods known in the art.

优选的实施方式如下:The preferred implementation is as follows:

实施例1:Example 1:

采用以下方法制备获得抗冻提取物:The antifreeze extract is prepared using the following method:

第一步:将成年虹鳟于2℃下饲养2周,收集400ml鱼血和300g鱼肉;The first step: raise adult rainbow trout at 2°C for 2 weeks, collect 400ml of fish blood and 300g of fish meat;

第二步:在2℃下,将鱼血和鱼肉放入闪式提取器,转速4400r/min,提取23s后50目滤网过滤,得粗滤提取液;Step 2: Put the fish blood and fish meat into the flash extractor at 2°C, rotate at 4400r/min, extract for 23 seconds and then filter through a 50-mesh filter to obtain a coarse-filtered extract;

第三步:在4℃下,向粗滤混合液中加入等体积的甘油,通过SV型静态混合器循环混合66s,150目过滤得精滤提取液,混合器空隙率为0.909%;Step 3: At 4°C, add an equal volume of glycerin to the coarse filter mixture, mix it cyclically for 66 seconds through an SV-type static mixer, and filter it with 150 mesh to obtain the fine filter extract. The void ratio of the mixer is 0.909%;

第四步:将混合液放入离心机,每5ml离心3min,转速6700r/min,取上清液;Step 4: Put the mixed solution into a centrifuge, centrifuge for 3 minutes per 5ml at a speed of 6700r/min, and take the supernatant;

第五步:将上清液于40℃下,真空度700mbar减压蒸馏至无液体继续流出,收集馏出液得抗冻提取物。Step 5: Distill the supernatant under reduced pressure at 40°C and a vacuum of 700 mbar until no liquid continues to flow out, and collect the distillate to obtain the antifreeze extract.

采用以下方法制备获得干细胞冻存液:Use the following method to prepare stem cell cryopreservation solution:

第一步:准备重量份数为54%的抗冻组合物和补足余量的干细胞培养基;抗冻组合物为重量份数为33%的抗冻提取物、重量份数为3%的原儿茶酸、重量份数为2%的香豆素、重量份数为6%的槲皮素和补足余量的甘油;Step 1: Prepare an antifreeze composition of 54% by weight and make up the remaining amount of stem cell culture medium; the antifreeze composition is an antifreeze extract of 33% by weight and a raw material of 3% by weight. Catechin, 2% by weight of coumarin, 6% by weight of quercetin and glycerol to make up the balance;

第二步:将上述组分25℃下混合搅拌20s后,得200ml体积的干细胞冻存液。Step 2: Mix and stir the above components at 25°C for 20 seconds to obtain a dry cell cryopreservation solution with a volume of 200 ml.

采用以下方法冻存干细胞:Stem cells are cryopreserved using the following methods:

第一步:25℃下将子宫内膜干细胞与干细胞冻存液搅拌混合,得降温体系,子宫内膜干细胞在降温体系中的最终数量密度为7×105/mL;The first step: stir and mix the endometrial stem cells and stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of endometrial stem cells in the cooling system is 7×10 5 /mL;

第二步:使用程序降温仪,将降温体系移入程序降温仪配套的各5ml冻存管中后放入程序降温仪中,启动程序降温仪以-2℃/ min的降温速率将温度降至-27℃,以-5℃/ min的降温速率将温度降至-78℃,以-11℃/ min的降温速率将温度降至-114℃;Step 2: Use the programmable cooling device, move the cooling system into each 5ml cryogenic tube provided with the programmable cooling device, and then put it into the programmable cooling device. Start the programmable cooling device to reduce the temperature to -2°C/min at a cooling rate. 27℃, reduce the temperature to -78℃ at a cooling rate of -5℃/min, and reduce the temperature to -114℃ at a cooling rate of -11℃/min;

第三步:将冻存管移入-196℃液氮,完成冻存。Step 3: Move the cryopreservation tube into -196°C liquid nitrogen to complete cryopreservation.

实施例2-25:Example 2-25:

实施例2与实施例1的区别仅在于干细胞冻存液组分的比例不同,实施例2的抗冻组合物的重量份数为43%;The only difference between Example 2 and Example 1 is the proportion of the components of the dry cell cryopreservation solution. The weight portion of the antifreeze composition of Example 2 is 43%;

实施例3与实施例1的区别仅在于干细胞冻存液组分的比例不同,实施例3的抗冻组合物的重量份数为58%;The only difference between Example 3 and Example 1 is the proportion of the components of the dry cell cryopreservation solution. The weight portion of the antifreeze composition of Example 3 is 58%;

实施例4与实施例1的区别仅在于干细胞冻存液组分的比例不同,实施例4的抗冻提取物的重量份数为30%;The only difference between Example 4 and Example 1 is that the proportion of the components of the dry cell cryopreservation solution is different. The weight portion of the antifreeze extract in Example 4 is 30%;

实施例5与实施例1的区别仅在于干细胞冻存液组分的比例不同,实施例5的抗冻提取物的重量份数为35%;The only difference between Example 5 and Example 1 is the proportion of the components of the dry cell cryopreservation solution. The weight portion of the antifreeze extract in Example 5 is 35%;

实施例6与实施例1的区别仅在于,实施例6的闪式提取器转速3600r/min;The only difference between Embodiment 6 and Embodiment 1 is that the rotation speed of the flash extractor in Embodiment 6 is 3600 r/min;

实施例7与实施例1的区别仅在于,实施例7的闪式提取器转速4700r/min;The only difference between Embodiment 7 and Embodiment 1 is that the rotation speed of the flash extractor in Embodiment 7 is 4700r/min;

实施例8与实施例1的区别仅在于,实施例8的闪式提取器提取时间17s;The only difference between Embodiment 8 and Embodiment 1 is that the extraction time of the flash extractor in Embodiment 8 is 17 seconds;

实施例9与实施例1的区别仅在于,实施例9的闪式提取器提取时间28s;The only difference between Embodiment 9 and Embodiment 1 is that the extraction time of the flash extractor in Embodiment 9 is 28 seconds;

实施例10与实施例1的区别仅在于,实施例10的SV型静态混合器循环混合60s;The only difference between Example 10 and Example 1 is that the SV-type static mixer of Example 10 circulates for 60 seconds;

实施例11与实施例1的区别仅在于,实施例11的SV型静态混合器循环混合70s;The only difference between Example 11 and Example 1 is that the SV-type static mixer of Example 11 circulates mixing for 70 seconds;

实施例12与实施例1的区别仅在于,实施例12的离心机转速6200r/min;The only difference between Example 12 and Example 1 is that the centrifuge speed of Example 12 is 6200 r/min;

实施例13与实施例1的区别仅在于,实施例13的离心机转速6900r/min;The only difference between Example 13 and Example 1 is that the centrifuge speed of Example 13 is 6900 r/min;

实施例14与实施例1的区别仅在于,实施例14的减压蒸馏真空度为600mbar;The only difference between Example 14 and Example 1 is that the vacuum degree of vacuum distillation in Example 14 is 600 mbar;

实施例15与实施例1的区别仅在于,实施例15的减压蒸馏真空度为800mbar;The only difference between Example 15 and Example 1 is that the vacuum degree of vacuum distillation in Example 15 is 800 mbar;

实施例16与实施例1的区别仅在于干细胞冻存方法不同,实施例16以-2℃/ min的降温速率将温度降至-25℃;The only difference between Example 16 and Example 1 is that the stem cell cryopreservation method is different. In Example 16, the temperature is lowered to -25°C at a cooling rate of -2°C/min;

实施例17与实施例1的区别仅在于干细胞冻存方法不同,实施例17以-2℃/ min的降温速率将温度降至-30℃;The only difference between Example 17 and Example 1 is that the stem cell cryopreservation method is different. In Example 17, the temperature is lowered to -30°C at a cooling rate of -2°C/min;

实施例18与实施例1的区别仅在于干细胞冻存方法不同,实施例18以-4℃/ min的降温速率将温度降至-78℃;The only difference between Example 18 and Example 1 is that the stem cell cryopreservation method is different. In Example 18, the temperature is lowered to -78°C at a cooling rate of -4°C/min;

实施例19与实施例1的区别仅在于干细胞冻存方法不同,实施例19以-6℃/ min的降温速率将温度降至-78℃;The only difference between Example 19 and Example 1 is that the stem cell cryopreservation method is different. In Example 19, the temperature is lowered to -78°C at a cooling rate of -6°C/min;

实施例20与实施例1的区别仅在于干细胞冻存方法不同,实施例20以-5℃/ min的降温速率将温度降至-75℃;The only difference between Example 20 and Example 1 is that the stem cell cryopreservation method is different. In Example 20, the temperature is lowered to -75°C at a cooling rate of -5°C/min;

实施例21与实施例1的区别仅在于干细胞冻存方法不同,实施例21以-5℃/ min的降温速率将温度降至-80℃;The only difference between Example 21 and Example 1 is that the stem cell cryopreservation method is different. In Example 21, the temperature is lowered to -80°C at a cooling rate of -5°C/min;

实施例22与实施例1的区别仅在于干细胞冻存方法不同,实施例22以-10℃/ min的降温速率将温度降至-114℃;The only difference between Example 22 and Example 1 is that the stem cell cryopreservation method is different. In Example 22, the temperature is lowered to -114°C at a cooling rate of -10°C/min;

实施例23与实施例1的区别仅在于干细胞冻存方法不同,实施例23以-12℃/ min的降温速率将温度降至-114℃;The only difference between Example 23 and Example 1 is that the stem cell cryopreservation method is different. In Example 23, the temperature is lowered to -114°C at a cooling rate of -12°C/min;

实施例24与实施例1的区别仅在于干细胞冻存方法不同,实施例24以-11℃/ min的降温速率将温度降至-110℃;The only difference between Example 24 and Example 1 is that the stem cell cryopreservation method is different. In Example 24, the temperature is lowered to -110°C at a cooling rate of -11°C/min;

实施例25与实施例1的区别仅在于干细胞冻存方法不同,实施例25以-11℃/ min的降温速率将温度降至-115℃。The only difference between Example 25 and Example 1 is the cryopreservation method of stem cells. In Example 25, the temperature was lowered to -115°C at a cooling rate of -11°C/min.

对比例1-3:Comparative Example 1-3:

对比例1采用购自武汉普诺赛生命科技有限公司的通用血清型程序冻存液,货号PB180436;Comparative Example 1 used the universal serotype procedure cryopreservation solution purchased from Wuhan Punosai Life Technology Co., Ltd., product number PB180436;

对比例2采用购自武汉普诺赛生命科技有限公司的牙髓干细胞,货号CP-H231;Comparative Example 2 used dental pulp stem cells purchased from Wuhan Pronosai Life Technology Co., Ltd., product number CP-H231;

对比例3采用购自武汉普诺赛生命科技有限公司的脂肪间充质干细胞,货号CP-H202。Comparative Example 3 used adipose mesenchymal stem cells purchased from Wuhan Pronosai Life Technology Co., Ltd., product number CP-H202.

对比例4-11与实施例1的干细胞冻存方法相同:The stem cell cryopreservation method of Comparative Examples 4-11 is the same as that of Example 1:

对比例4与实施例1的区别仅在于对比例4的干细胞冻存液为重量份数为70%的抗冻组合物和补足余量的干细胞培养基;The only difference between Comparative Example 4 and Example 1 is that the stem cell cryopreservation solution in Comparative Example 4 is an antifreeze composition of 70% by weight and a stem cell culture medium that makes up the balance;

对比例5与实施例1的区别仅在于对比例5的抗冻组合物中抗冻提取物的重量份数为45%;The only difference between Comparative Example 5 and Example 1 is that the weight portion of the antifreeze extract in the antifreeze composition of Comparative Example 5 is 45%;

对比例6与实施例1的区别仅在于对比例6将抗冻提取物替换为III型HPLC-12抗冻蛋白,将原儿茶酸、香豆素和槲皮素替换为白藜芦醇;The only difference between Comparative Example 6 and Example 1 is that in Comparative Example 6, the antifreeze extract was replaced by type III HPLC-12 antifreeze protein, and protocatechuic acid, coumarin and quercetin were replaced by resveratrol;

对比例7与实施例1的区别仅在于对比例7闪式提取器转速为6000r/min;The only difference between Comparative Example 7 and Example 1 is that the rotation speed of the flash extractor in Comparative Example 7 is 6000r/min;

对比例8与实施例1的区别仅在于对比例8闪式提取器提取时间为60min;The only difference between Comparative Example 8 and Example 1 is that the flash extractor extraction time of Comparative Example 8 is 60 minutes;

对比例9与实施例1的区别仅在于对比例9的SV型静态混合器循环混合100s;The only difference between Comparative Example 9 and Example 1 is that the SV-type static mixer of Comparative Example 9 circulates mixing for 100 seconds;

对比例10与实施例1的区别仅在于对比例10离心机转速8000r/min;The only difference between Comparative Example 10 and Example 1 is that the centrifuge speed of Comparative Example 10 is 8000r/min;

对比例11与实施例1的区别仅在于对比例11减压蒸馏的真空度为1000mbar。The only difference between Comparative Example 11 and Example 1 is that the vacuum degree of vacuum distillation in Comparative Example 11 is 1000 mbar.

对比例12-14与实施例1的干细胞冻存液相同:Comparative Examples 12-14 are the same as the stem cell cryopreservation solution of Example 1:

对比例12与实施例1的区别仅在于对比例12以-2℃/ min的降温速率将温度降至-27℃,以-5℃/ min的降温速率将温度降至-78℃;移入-196℃液氮,完成冻存;The only difference between Comparative Example 12 and Example 1 is that Comparative Example 12 lowered the temperature to -27°C at a cooling rate of -2°C/min and to -78°C at a cooling rate of -5°C/min; move into - 196℃ liquid nitrogen, complete cryopreservation;

对比例13与实施例1的区别仅在于对比例13以-2℃/ min的降温速率将温度降至-114℃;移入-196℃液氮,完成冻存;The only difference between Comparative Example 13 and Example 1 is that Comparative Example 13 lowered the temperature to -114°C at a cooling rate of -2°C/min; moved it into -196°C liquid nitrogen to complete freezing;

对比例14与实施例1的区别仅在于对比例14以-2℃/ min的降温速率将温度降至-25℃,以-5℃/ min的降温速率将温度降至-100℃;移入-196℃液氮,完成冻存。The only difference between Comparative Example 14 and Example 1 is that Comparative Example 14 lowered the temperature to -25°C at a cooling rate of -2°C/min and to -100°C at a cooling rate of -5°C/min; move into - Liquid nitrogen at 196°C to complete cryopreservation.

对比例15如下:Comparative Example 15 is as follows:

采用以下方法制备获得抗冻提取物:The antifreeze extract is prepared using the following method:

第一步:将成年虹鳟于2℃下饲养2周,收集400ml鱼血和300g鱼肉;The first step: raise adult rainbow trout at 2°C for 2 weeks, collect 400ml of fish blood and 300g of fish meat;

第二步:在2℃下,将鱼血和鱼肉放入闪式提取器,转速4400r/min,提取23s后50目滤网过滤,得粗滤提取液;Step 2: Put the fish blood and fish meat into the flash extractor at 2°C, rotate at 4400r/min, extract for 23 seconds and then filter through a 50-mesh filter to obtain a coarse-filtered extract;

第三步:在4℃下,向粗滤混合液中加入等体积的甘油,通过SV型静态混合器循环混合66s,150目过滤得精滤提取液,混合器空隙率为0.88%;Step 3: At 4°C, add an equal volume of glycerin to the coarse filter mixture, circulate it through an SV-type static mixer for 66 seconds, and filter it with 150 mesh to obtain a fine filter extract. The void ratio of the mixer is 0.88%;

第四步:将混合液放入离心机,每5ml离心3min,转速6700r/min,取上清液;Step 4: Put the mixed solution into a centrifuge, centrifuge for 3 minutes per 5ml at a speed of 6700r/min, and take the supernatant;

第五步:将上清液于50℃下,真空度700mbar减压蒸馏至无液体继续流出,收集馏出液得抗冻提取物。Step 5: Distill the supernatant under reduced pressure at 50°C and a vacuum of 700 mbar until no liquid continues to flow out, and collect the distillate to obtain the antifreeze extract.

采用以下方法制备获得干细胞冻存液:Use the following method to prepare stem cell cryopreservation solution:

第一步:准备重量份数为54%的抗冻组合物和补足余量的干细胞培养基;抗冻组合物为重量份数为33%的抗冻提取物、重量份数为5%的原儿茶酸、重量份数为4%的香豆素、重量份数为9%的槲皮素和补足余量的甘油;Step 1: Prepare an antifreeze composition of 54% by weight and make up the remaining amount of stem cell culture medium; the antifreeze composition is an antifreeze extract of 33% by weight and 5% of the original Catechin, 4% by weight of coumarin, 9% by weight of quercetin and glycerin to make up the balance;

第二步:将上述组分25℃下混合搅拌20s后,得200ml体积的干细胞冻存液。Step 2: Mix and stir the above components at 25°C for 20 seconds to obtain a dry cell cryopreservation solution with a volume of 200 ml.

采用以下方法冻存干细胞:Stem cells are cryopreserved using the following methods:

第一步:25℃下将子宫内膜干细胞与干细胞冻存液混合,得降温体系,子宫内膜干细胞在降温体系中的最终数量密度为7×106/mL;Step one: Mix endometrial stem cells and stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of endometrial stem cells in the cooling system is 7×10 6 /mL;

第二步:使用程序降温仪,将降温体系移入程序降温仪配套的各5ml冻存管中后放入程序降温仪中,启动程序降温仪以-2℃/ min的降温速率将温度降至-20℃,以-8℃/ min的降温速率将温度降至-85℃,以-15℃/ min的降温速率将温度降至-100℃;Step 2: Use the programmable cooling device, move the cooling system into each 5ml cryogenic tube provided with the programmable cooling device, and then put it into the programmable cooling device. Start the programmable cooling device to reduce the temperature to -2°C/min at a cooling rate. 20℃, reduce the temperature to -85℃ at a cooling rate of -8℃/min, and reduce the temperature to -100℃ at a cooling rate of -15℃/min;

第三步:移入-196℃液氮,完成冻存。Step 3: Move into -196°C liquid nitrogen to complete freezing.

对上述各示例的子宫内膜干细胞各准备12组冻存40天,带冻存管放入37℃温水轻晃在90s内融化复苏,取1~6组测试存活率和增殖能力,7~12组按照本发明的冻存方法再次冻存40天,反复冻融至第三次复苏后,测试7~12组的反复冻融的存活率和增殖能力。Prepare 12 groups of endometrial stem cells from each of the above examples for cryopreservation for 40 days. Place cryopreservation tubes in warm water at 37°C and gently shake them for thawing and recovery within 90 seconds. Take 1 to 6 groups to test the survival rate and proliferation ability, and 7 to 12 groups. Groups were frozen again for 40 days according to the cryopreservation method of the present invention. After repeated freezing and thawing until the third recovery, the survival rate and proliferation ability of groups 7 to 12 were tested after repeated freezing and thawing.

存活率测试:Survival test:

取出各示例1~3组和7~9组的冻存管,打开盖子,用吸管吸出细胞悬液,加到离心管并加10倍以上干细胞培养基,混匀;1000rpm离心5min;弃去上清液,加入含10%购自默克化工技术(上海)有限公司的货号RAB1347的小牛血清培养液重悬细胞,每1ml细胞悬液加购自武汉普诺赛生命科技有限公司台盼蓝染液2滴,室温下染4min,染色过的细胞材料,取一滴细胞悬液置玻片上,加盖玻片后放高倍镜下观察;死亡的细胞着浅蓝色并膨大,无光泽;活细胞不着色并保持正常形态,有光泽;计活和死细胞数,按细胞活率(%)=未染色的细胞数/观察的细胞总数×100%的公式计算出细胞活率。Take out the cryovials from groups 1 to 3 and 7 to 9 in each example, open the lid, suck out the cell suspension with a pipette, add it to the centrifuge tube and add 10 times more stem cell culture medium, mix well; centrifuge at 1000 rpm for 5 minutes; discard the supernatant To the supernatant, add 10% calf serum culture medium purchased from Merck Chemical (Shanghai) Co., Ltd. (Cat. No. RAB1347) to resuspend the cells. Add trypan blue purchased from Wuhan Pronosei Life Technology Co., Ltd. to every 1 ml of cell suspension. Dye 2 drops of dye solution at room temperature for 4 minutes. For the stained cell material, take a drop of cell suspension and place it on a glass slide. Add a cover slip and observe under a high-power microscope; dead cells are light blue and enlarged and dull; viable cells are light blue and enlarged and dull. The cells are not stained and maintain normal shape and are shiny; count the number of live and dead cells, and calculate the cell viability according to the formula: cell viability (%) = number of unstained cells/total number of cells observed × 100%.

各示例存活率测试结果见表1。在表1中,存活率测试结果取各示例1~3组结果的平均值和7~9组结果的平均值并保留至整数位。The survival rate test results of each example are shown in Table 1. In Table 1, the survival rate test results take the average of the results of groups 1 to 3 and the average of the results of groups 7 to 9 of each example and keep them to integers.

由表1中的数据可知,相较于其他各示例,本发明实施例1~25的细胞存活率更高,本发明实施例1~25的子宫内膜干细胞复苏后尤其是反复冻融后有较其他技术方案突出的存活率。It can be seen from the data in Table 1 that compared with other examples, the cell survival rate of Examples 1 to 25 of the present invention is higher. The endometrial stem cells of Examples 1 to 25 of the present invention have better survival rates after recovery, especially after repeated freezing and thawing. Outstanding survival rate compared to other technical solutions.

增殖能力测试:Proliferation ability test:

本发明实施例1具有的细胞存活率最高,为进一步筛选实施范围,并验证本发明实施例对其他示例的优越性,对各示例冻存的4~6组和10~12组子宫内膜干细胞进行复苏,复苏后加到离心管并加10倍以上干细胞培养基,混匀;1000rpm离心5min,使用购自默克化工技术(上海)有限公司的货号为P3744-12PAK的PBS缓冲液冲洗去除冻存液。重悬后按照1×103个/每孔的的密度接种于96孔板,加入适量干细胞培养基,使其贴壁生长。计算细胞增殖倍率达1.3的时间,计至100h。Embodiment 1 of the present invention has the highest cell survival rate. In order to further screen the implementation scope and verify the superiority of the embodiment of the present invention over other examples, 4 to 6 groups and 10 to 12 groups of endometrial stem cells cryopreserved in each example were Resuscitate, add to the centrifuge tube and add 10 times more stem cell culture medium, mix well; centrifuge at 1000rpm for 5 minutes, rinse with PBS buffer with product number P3744-12PAK purchased from Merck Chemical (Shanghai) Co., Ltd. to remove the freeze. Reserve liquid. After resuspension, seed the cells in a 96-well plate at a density of 1×10 3 cells/well, and add an appropriate amount of stem cell culture medium to allow them to grow adherently. The time for the cell proliferation rate to reach 1.3 was calculated to 100 h.

各示例增殖能力测试结果见表2。在表2中,增殖能力测试结果取各示例4~6组结果的平均值和10~12组结果的平均值并保留至整数位。The proliferative ability test results of each example are shown in Table 2. In Table 2, the proliferation ability test results are taken as the average of the results of groups 4 to 6 and the average of the results of groups 10 to 12 of each example and are kept to the integer.

由表2中的数据可知,相较于其他各示例,本发明实施例1~25的细胞增殖倍率达1.3的时间更短,本发明实施例1~25的子宫内膜干细胞复苏后和反复冻融后有较其他技术方案突出的增殖能力。进一步的本发明实施例1相对与本发明的其他实施例的细胞增殖倍率达1.3的时间更短,本发明实施例1的子宫内膜干细胞复苏后有较其他实施例方案突出的增殖能力。综上,本发明最佳的实施方式为实施例1。It can be seen from the data in Table 2 that compared with other examples, the time for the cell proliferation rate of Examples 1 to 25 of the present invention to reach 1.3 is shorter. After the endometrial stem cells of Examples 1 to 25 of the present invention are revived and repeatedly frozen After fusion, it has outstanding proliferative capabilities compared with other technical solutions. Furthermore, the time required for the cell proliferation rate to reach 1.3 in Example 1 of the present invention is shorter than that of other embodiments of the present invention. The endometrial stem cells of Example 1 of the present invention have outstanding proliferation ability after recovery compared with other embodiments. In summary, the best implementation mode of the present invention is Embodiment 1.

需要注意的是,本发明为针对人子宫内膜干细胞的优选实验,对照对比例2和3,本发明的实施方式对人子宫内膜干细胞的效果显著优于其他种类干细胞。对照对比例1,本发明也解决了通用冻存液对人子宫内膜干细胞的冻存效果较差的问题。It should be noted that the present invention is a preferred experiment for human endometrial stem cells. Compared with Comparative Examples 2 and 3, the effect of the embodiments of the present invention on human endometrial stem cells is significantly better than other types of stem cells. Compared with Comparative Example 1, the present invention also solves the problem of poor cryopreservation effect of universal cryopreservation solution on human endometrial stem cells.

以上所述仅为本发明的实施例而已,并不用于限制本发明;对于本领域技术人员来说,本发明可以有各种更改和变化;凡在本发明的精神和原理之内所作的任何修改、等同替换、改进等,均应包含在本发明的权利要求范围之内。The above are only examples of the present invention and are not intended to limit the present invention; for those skilled in the art, the present invention may have various modifications and changes; any modifications made within the spirit and principles of the present invention Modifications, equivalent substitutions, improvements, etc. shall be included in the scope of the claims of the present invention.

Claims (9)

1.一种干细胞冻存液,其特征在于,所述干细胞冻存液由以下组分组成:1. A stem cell cryopreservation solution, characterized in that the stem cell cryopreservation solution consists of the following components: 重量份数为43~58%的抗冻组合物和补足余量的干细胞培养基;The antifreeze composition is 43~58% by weight and the stem cell culture medium makes up the balance; 所述抗冻组合物为重量份数为30~35%的抗冻提取物、重量份数为3%的原儿茶酸、重量份数为2%的香豆素、重量份数为6%的槲皮素和补足余量的甘油;The antifreeze composition is 30 to 35% by weight of antifreeze extract, 3% by weight of protocatechuic acid, 2% by weight of coumarin, and 6% by weight. of quercetin and glycerin to make up the balance; 所述抗冻提取物的提取方法包括:The extraction method of the antifreeze extract includes: 步骤一:将成年虹鳟于2℃下饲养2周,收集400ml鱼血和300g鱼肉;Step 1: Raise adult rainbow trout at 2°C for 2 weeks, collect 400ml of fish blood and 300g of fish meat; 步骤二:在2℃下,将鱼血和鱼肉放入闪式提取器,转速3600~4700r/min,提取17~28s后50目滤网过滤,得粗滤提取液;Step 2: Put the fish blood and fish meat into the flash extractor at 2°C, rotate at 3600~4700r/min, extract for 17~28s and then filter through a 50-mesh filter to obtain a coarse-filtered extract; 步骤三:在4℃下,向粗滤混合液中加入等体积的甘油,通过SV型静态混合器循环混合60~70s,150目过滤得精滤提取液,混合器空隙率为0.909%;Step 3: At 4°C, add an equal volume of glycerin to the coarse filter mixture, mix it in a SV-type static mixer for 60 to 70 seconds, and filter it with 150 mesh to obtain a fine filter extract. The void ratio of the mixer is 0.909%; 步骤四:将混合液放入离心机,每5ml离心3min,转速6200~6900r/min,取上清液;Step 4: Put the mixed solution into a centrifuge, centrifuge for 3 minutes per 5ml at a speed of 6200~6900r/min, and take the supernatant; 步骤五:将上清液于40℃下,真空度600~800mbar减压蒸馏至无液体继续流出,收集馏出液得抗冻提取物。Step 5: Distill the supernatant under reduced pressure at 40°C with a vacuum of 600~800mbar until no liquid continues to flow out, and collect the distillate to obtain the antifreeze extract. 2.根据权利要求1所述的干细胞冻存液,其特征在于,所述抗冻组合物的重量份数为54%。2. The stem cell cryopreservation solution according to claim 1, wherein the weight portion of the antifreeze composition is 54%. 3.根据权利要求1所述的干细胞冻存液,其特征在于,所述抗冻提取物的重量份数为33%。3. The stem cell cryopreservation solution according to claim 1, wherein the weight portion of the antifreeze extract is 33%. 4.根据权利要求1所述的干细胞冻存液,其特征在于,所述步骤二中闪式提取过程为4400r/min,提取23s。4. The stem cell cryopreservation solution according to claim 1, characterized in that the flash extraction process in step 2 is 4400 r/min and the extraction takes 23 seconds. 5.根据权利要求1所述的干细胞冻存液,其特征在于,所述步骤三中混合时间为66s。5. The stem cell cryopreservation solution according to claim 1, characterized in that the mixing time in step three is 66 seconds. 6.根据权利要求1所述的干细胞冻存液,其特征在于,所述步骤四中离心转速为6700r/min。6. The stem cell cryopreservation solution according to claim 1, wherein the centrifugal speed in step 4 is 6700 r/min. 7.根据权利要求1所述的干细胞冻存液,其特征在于,所述步骤五中真空度为700mbar。7. The stem cell cryopreservation solution according to claim 1, wherein the vacuum degree in step five is 700 mbar. 8.一种使用如权利要求1~7任一所述的干细胞冻存液的干细胞冻存方法,其特征在于,所述干细胞冻存方法包括:8. A stem cell cryopreservation method using the stem cell cryopreservation solution according to any one of claims 1 to 7, characterized in that the stem cell cryopreservation method includes: 步骤一:25℃下将子宫内膜干细胞与所述干细胞冻存液混合,得降温体系,所述子宫内膜干细胞在所述降温体系中的最终数量密度为7×105/mL;Step 1: Mix endometrial stem cells and the stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of the endometrial stem cells in the cooling system is 7×10 5 /mL; 步骤二:使用程序降温仪,以-2℃/ min的降温速率将温度降至-25~-30℃,以-4~-6℃/min的降温速率将温度降至-75~-80℃,以-10~-12℃/ min的降温速率将温度降至-110~-115℃;Step 2: Use the programmed cooling device to lower the temperature to -25~-30°C at a cooling rate of -2°C/min, and to -75~-80°C at a cooling rate of -4~-6°C/min. , reduce the temperature to -110~-115°C at a cooling rate of -10~-12°C/min; 步骤三:移入-196℃液氮,完成冻存。Step 3: Move into -196°C liquid nitrogen to complete freezing. 9.根据权利要求8所述的干细胞冻存方法,其特征在于,所述干细胞冻存方法包括:9. The stem cell cryopreservation method according to claim 8, characterized in that the stem cell cryopreservation method includes: 步骤一:25℃下将子宫内膜干细胞与所述干细胞冻存液混合,得降温体系,所述子宫内膜干细胞在所述降温体系中的最终数量密度为7×105/mL;Step 1: Mix endometrial stem cells and the stem cell cryopreservation solution at 25°C to obtain a cooling system. The final number density of the endometrial stem cells in the cooling system is 7×10 5 /mL; 步骤二:使用程序降温仪,以-2℃/ min的降温速率将温度降至-27℃,以-5℃/ min的降温速率将温度降至-78℃,以-11℃/ min的降温速率将温度降至-114℃;Step 2: Use the programmed cooling device to lower the temperature to -27°C at a cooling rate of -2°C/min, to -78°C at a cooling rate of -5°C/min, and to -11°C/min. rate reduces the temperature to -114°C; 步骤三:移入-196℃液氮,完成冻存。Step 3: Move into -196°C liquid nitrogen to complete freezing.
CN202311007396.8A 2023-08-11 2023-08-11 Stem cell cryopreservation solution and stem cell cryopreservation method Active CN116725003B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311007396.8A CN116725003B (en) 2023-08-11 2023-08-11 Stem cell cryopreservation solution and stem cell cryopreservation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311007396.8A CN116725003B (en) 2023-08-11 2023-08-11 Stem cell cryopreservation solution and stem cell cryopreservation method

Publications (2)

Publication Number Publication Date
CN116725003A CN116725003A (en) 2023-09-12
CN116725003B true CN116725003B (en) 2023-10-24

Family

ID=87906361

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311007396.8A Active CN116725003B (en) 2023-08-11 2023-08-11 Stem cell cryopreservation solution and stem cell cryopreservation method

Country Status (1)

Country Link
CN (1) CN116725003B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117050933B (en) * 2023-10-11 2023-12-26 赛尔医学科技(山东)有限公司 Stem cell culture medium and application method thereof
CN118240775B (en) * 2024-05-29 2024-08-27 丽山健康(山东)集团有限公司 Adeno-associated virus storage method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076380A1 (en) * 1991-01-17 1992-07-18 Boris Rubinsky Compositions to improve survival of biological materials
CN1454990A (en) * 2003-05-30 2003-11-12 北京大学第一医院 Human egg mother cell storage method
JP2006124295A (en) * 2004-10-27 2006-05-18 National Institute Of Advanced Industrial & Technology Antifreeze protein mixture
CN104673748A (en) * 2015-03-19 2015-06-03 河南中科干细胞基因工程有限公司 Method for extracting mesenchymal stem cells from human umbilical cord
CN107114357A (en) * 2017-06-13 2017-09-01 广州赛莱拉干细胞科技股份有限公司 The frozen stock solution and its cryopreservation methods of a kind of periodontal ligament stem cell
CN110338187A (en) * 2018-04-08 2019-10-18 生物角(厦门)科技有限公司 A kind of mesenchymal stem cell serum-free cryopreservation composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4228068B2 (en) * 2001-11-21 2009-02-25 独立行政法人産業技術総合研究所 Antifreeze protein derived from fish

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076380A1 (en) * 1991-01-17 1992-07-18 Boris Rubinsky Compositions to improve survival of biological materials
CN1454990A (en) * 2003-05-30 2003-11-12 北京大学第一医院 Human egg mother cell storage method
JP2006124295A (en) * 2004-10-27 2006-05-18 National Institute Of Advanced Industrial & Technology Antifreeze protein mixture
CN104673748A (en) * 2015-03-19 2015-06-03 河南中科干细胞基因工程有限公司 Method for extracting mesenchymal stem cells from human umbilical cord
CN107114357A (en) * 2017-06-13 2017-09-01 广州赛莱拉干细胞科技股份有限公司 The frozen stock solution and its cryopreservation methods of a kind of periodontal ligament stem cell
CN110338187A (en) * 2018-04-08 2019-10-18 生物角(厦门)科技有限公司 A kind of mesenchymal stem cell serum-free cryopreservation composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"白斑狗鱼鱼肉中抗冻蛋白的分离".《中国酿造》.2015,(第2期),第120-125页. *
抗冻蛋白研究进展;冯从经;陆剑锋;吕文静;董秋安;符文俊;;江苏农业学报(第05期);全文 *
淡水瓦氏雅罗鱼基因文库的构建和抗冻蛋白基因同源序列的筛选;费云标,于建康,陈良标,王亚平,王为先,毛钟荣,严绍颐,靳光琴;发育与生殖生物学报(英文版)(第01期);第23页 *

Also Published As

Publication number Publication date
CN116725003A (en) 2023-09-12

Similar Documents

Publication Publication Date Title
CN116725003B (en) Stem cell cryopreservation solution and stem cell cryopreservation method
CN108617638B (en) Tissue and/or cell cryopreservation solution and preparation and application thereof
CA2719806A1 (en) Method, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue
RU2416197C1 (en) Method of cryopreservation of hematopoietic stem cells of umbilical blood
CN110074096A (en) A kind of serum-free cell frozen stock solution and its preparation method and application
CN112772637A (en) DMSO-free human umbilical cord mesenchymal stem cell injection frozen stock solution
CN110800733A (en) A kind of cryopreservation solution and kit for umbilical cord mesenchymal stem cells
CN107711823B (en) A kind of cell cryopreservation solution stored at room temperature and its application
CN116998475A (en) A tissue preservation solution for preservation and transportation of fresh tumor tissue and its application
CN108077243A (en) A kind of freezen protective Human plactnta amnion and chorial protection liquid and preparation method thereof and application method
CN106417253A (en) Cryopreservation liquid and method for skeletal muscle stem cells
Gray et al. In vitro colony formation by human bone marrow cells after freezing
Kuleshova et al. Vitrification of encapsulated hepatocytes with reduced cooling/warming rates
CN108029679B (en) A freezing medium for cryopreservation of mononuclear cells
JP4385158B2 (en) Cell preservation solution and cell preservation method using the preservation solution
CN114317419A (en) Method for constructing muscle cell line of Gymnocypris przewalskii
CN112438252B (en) Tissue freezing and thawing method suitable for mouse heart tissue single cell sequencing
CN114190368B (en) Serum-free immune cell cryopreservation liquid, preparation method and immune cell cryopreservation method
CN115152743A (en) A kind of preparation method of human umbilical cord mesenchymal stem cell serum-free cryopreservation solution
CN115299432A (en) Preparation method of hydrogel for stem cell encapsulation and preservation
CN107384866A (en) A kind of people's primary tumor cell method for separating and preparing
US20190357524A1 (en) Preservative solution for human stem cells, human stem cell suspension, and method for preserving human stem cells
CN100463963C (en) A kind of cryopreservation method of domestic pig skin tissue
CN118633593B (en) Tissue freezing solution for single cell sequencing and preparation method and application thereof
CN113133445B (en) Preservation method, transportation method and treatment method of mesenchymal stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant